Virtus ETF Advisers LLC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$283,000
-58.1%
58,544
-7.8%
0.12%
+5.5%
Q4 2019$675,000
+32.6%
63,484
+29.8%
0.11%
+6.8%
Q3 2019$509,000
-41.8%
48,906
-14.4%
0.10%
-44.0%
Q2 2019$875,000
+153.6%
57,127
+112.7%
0.18%
-74.9%
Q1 2019$345,000
+22.3%
26,854
-9.7%
0.73%
+1429.2%
Q4 2018$282,000
-36.5%
29,723
+11.2%
0.05%
+4.3%
Q3 2018$444,000
-39.7%
26,741
-41.7%
0.05%
-92.9%
Q2 2018$736,000
-7.0%
45,850
-11.3%
0.65%
-5.1%
Q1 2018$791,000
+111.5%
51,678
+115.7%
0.69%
+46.3%
Q4 2017$374,00023,9580.47%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q1 2020.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders